Novartis Looks To Take Its Diversity Show On The Road
Company In Early Stages Of International Expansion
Executive Summary
Head of clinical trial diversity and inclusion Kim Fookes spoke with Scrip about Novartis’s US trial diversity initiatives and early plans to expand them abroad.
You may also be interested in...
Pivotal Trials For EU Approval Still Underrepresent Minorities, Study Finds
Data on minority groups were frequently underreported, and in many cases numbers have not improved with time, according to the study by Tufts CSDD.
Pivotal Trials For EU Approval Still Underrepresent Minorities, Study Finds
The study, by Tufts CSDD, also found that data on minority groups were frequently underreported, and in many cases numbers have not improved with time.
Has There Been A Sea Change In Trial Diversity Efforts?
PhRMA partnered with Deloitte to produce a report that included a survey of 31 member companies indicating that most had made significant investments in improving clinical trial diversity.